A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Completed · Phase 3 · Has a placebo group

Conditions studied: Papulopustular Rosacea, Erythematotelangiectatic Rosacea

In brief

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Key facts

Study ID
NCT02393937
Run by
bioRASI, LLC
People needed
963
Starts
2015-02-01
Expected to finish
2015-10-01
Last updated by the study team
2020-09-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.